Medine.co.uk

Clamoxyl Ready-To-Use 150 Mg/Ml Suspension For Injection

Revised: June 2014

AN: 00245/2014

SUMMARY OF PRODUCT CHARACTERISTICS


NAME OF THE VETERINARY MEDICINAL PRODUCT


Clamoxyl Ready-To-Use 150 mg/ml suspension for injection


QUALITATIVE AND QUANTITATIVE COMPOSITION


Active Substance mg/ml

Amoxicillin 150

(As Amoxicillin trihydrate)

For a full list of excipients please see section 6.1


PHARMACEUTICAL FORM


Suspension for injection

A white to off white oily suspension


CLINICAL PARTICULARS


Target species

Dogs, cats, sheep, pigs and cattle


Indications for use, specifying the target species


For the treatment of infections caused by susceptible organisms in dogs, cats, sheep, pigs and cattle. The product is not effective against beta-lactamase producing organisms.


Contraindications


Not to be used in rabbits, guinea pigs, hamsters or gerbils.

The suspension is not suitable for intravenous or intrathecal administration.


Special warnings for each target species


None


Special precautions for use


Special precautions for use in animals


Do not use in animals with known sensitivity to the active substance.

Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local epidemiological information.

This product does not contain an antimicrobial preservative.


Special precautions to be taken by the person administering the veterinary medicinal product to animals


Care should be taken to avoid accidental self injection.

Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reaction to these substances may occasionally be serious.

Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.

Handle this product with great care to avoid exposure taking all recommended precautions.

If you develop symptoms following exposure, such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing, are more serious symptoms and require urgent medical attention.

Wash hands after use.


Adverse reactions (frequency and seriousness)


Use of the product may result in local tissue reaction.


Use during pregnancy, lactation or lay


None


Interaction with other medicinal products and other forms of interaction


None known


Amounts to be administered and administration route


The recommended dosage rate is 7 mg/kg bodyweight once daily for up to 5 days by subcutaneous (dogs, cats), or intramuscular (dogs, cats, sheep, pigs and cattle) injection.

If the volume to be given is greater than 15 ml (cattle) and 5 ml (sheep and pigs) the dose should be divided and the remaining should be injected in another site.

Shake the vial well to suspend the active ingredient before use.

Swab rubber septum and remove required volume aseptically.

Do not breach more than 40 times.

Massage the injection site after administration. Use a new anatomical site for repeated injections. To ensure the correct dosage, bodyweight should be determined as accurately as possible to avoid overdosing.

In common with other penicillin preparations hydrolysis takes place rapidly in the presence of water. It is important therefore that a dry syringe is used when extracting the suspension for injection to avoid contaminating the remaining contents of the vial with drops of water.


Overdose (symptoms, emergency procedures, antidotes), if necessary


Amoxicillin is of a very low order of acute toxicity and is well tolerated by the parenteral route. Occasional injection site reactions may occur with the recommended dose, but no other adverse side effects are to be expected from accidental overdosing.


Withdrawal periods


Meat: Cattle: 54 days

Sheep: 47 days

Pigs: 47 days


Milk: Cattle: 60 hours from the last treatment.

Not to be used in sheep producing milk for human consumption.


PHARMACOLOGICAL PROPERTIES


ATCVet Code:QJ01CA04


Amoxicillin is a broad-spectrum semi-synthetic penicillin which is bactericidal in vitro against a wide range of Gram-positive and Gram-negative bacteria including the following: Actinomyces spp., Bacillus spp., Bordetella bronchiseptica, Clostridium spp., Corynebacterium spp, Escherichia coli, Fusobacterium spp., Haemophilus spp., Leptospira spp., Moraxella spp., Pasteurella spp., Proteus spp., Salmonella spp., Streptococci, Staphylococci(penicillin-sensitive strains).

Clamoxyl Ready-To-Use Injection is indicated for the treatment of infections caused by Amoxicillin-sensitive organisms in dogs, cats, sheep, pigs and cattle.


PHARMACEUTICAL PARTICULARS


List of excipients


Polysorbate 80

Aluminium Stearate

Ethyl Oleate


Incompatibilities


None known


Shelf-life


Shelf life of the veterinary medicinal product as packaged for sale: 3 years.

Shelf life after first opening the immediate packaging: 28 days.


Special precautions for storage


Do not store above 25°C.

Following withdrawal of the first dose, use the product within 28 days. Discard unused material.


Nature and composition of immediate packaging


Carton containing 6 100ml clear colourless type III glass vials with chlorobutyl bungs with an aluminium overseal.

Carton containing 4 250ml clear colourless type II or type III glass vials with chlorobutyl bungs with an aluminium overseal.

Not all pack sizes may be marketed.


Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products, if appropriate


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.


MARKETING AUTHORISATION HOLDER


Zoetis UK Limited

5th Floor, 6 St. Andrew Street

London

EC4A 3AE


MARKETING AUTHORISATION NUMBER


Vm:42058/4016


DATE OF THE FIRST AUTHORISATION


Date:03 December 1990


DATE OF REVISION OF THE TEXT


Date:June 2014


26 June 2014